Evidence map›Paper›PMID 30463297›Full record

ReviewVaccines2018

The Immunomodulatory and Antimicrobial Properties of the Vertebrate Ribonuclease A Superfamily.

Laura Schwartz, Ariel Cohen, Jason Thomas, John David Spencer

Open access · goldAbstract readReview
In one paragraph

Review in Vaccines, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Synthetic Polymers for Drug, Gene, and Vaccine Delivery.Polymer science & technology (Washington, D.C.) · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Expression and function of human ribonuclease 4 in the kidney and urinary tract.American journal of physiology. Renal physiology · 2021
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Endothelial Ribonuclease 1 in Cardiovascular and Systemic Inflammation.Frontiers in cell and developmental biology · 2020
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Laura SchwartzCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's, Columbus, OH 43205, USA. laura.schwartz@nationwidechildrens.org.ORCID 0000-0002-4056-3030
Ariel CohenCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's, Columbus, OH 43205, USA. acohen4@wellesley.edu.
Jason ThomasDivision of Nephrology, Department of Pediatrics, Nationwide Children's, Columbus, OH 43205, USA. jason.thomas@nationwidechildrens.org.
John David SpencerCenter for Clinical and Translational Research, The Research Institute at Nationwide Children's, Columbus, OH 43205, USA. john.spencer@nationwidechildrens.org.ORCID 0000-0001-5509-7135
Nationwide Children's Hospital · US

Funding

The Contributions of Ribonuclease 4 & 7 to Urinary Tract Antibacterial DefenseR01DK115737 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI John David Spencer · 2018 to 2026
$2.8M
Linking Insulin Signaling to Antimicrobial Peptide Production and the Kidney's Antibacterial DefensesR01DK114035 · NIDDK · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI SPENCER, JOHN DAVID · 2018 to 2021
$1.4M
NIDDK NIH HHS R01 DK114035NIDDK NIH HHS R01 DK115737
6 · The paper itself

Abstract

The Ribonuclease A Superfamily is composed of cationic peptides that are secreted by immune cells and epithelial tissues. Although their physiological roles are unclear, several members of the vertebrate Ribonuclease A Superfamily demonstrate antimicrobial and immune modulation activities. The objective of this review is to provide an overview of the published literature on the Ribonuclease A Superfamily with an emphasis on each peptide's regulation, antimicrobial properties, and immunomodulatory functions. As additional insights emerge regarding the mechanisms in which these ribonucleases eradicate invading pathogens and modulate immune function, these ribonucleases may have the potential to be developed as a novel class of therapeutics for some human diseases.

Indexed as

infectioninflammationinnate immunityribonuclease A superfamilyribonucleases

Identifiers

PMID30463297
PMCPMC6313885
OpenAlexW2901054167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.